S627: A review of serious adverse drug reactions (ADRS) from dupilumab (dupixent) reported to the Federal Adverse Event Reporting System (FAERS)

Yannis Lafazanos; Eli D. Ehrenpreis

doi:10.14309/01.ajg.0001031876.62582.d1

S627: A review of serious adverse drug reactions (ADRS) from dupilumab (dupixent) reported to the Federal Adverse Event Reporting System (FAERS)

Yannis Lafazanos
, Eli D. Ehrenpreis

Research output: Contribution to journal › Meeting abstract

Original language	American English
Journal	American Journal of Gastroenterology
DOIs	https://doi.org/10.14309/01.ajg.0001031876.62582.d1
Status	Published - Oct 1 2024

Access to Document

10.14309/01.ajg.0001031876.62582.d1License: Unspecified

http://institutionalrepository.aah.org/advocategme/1237

Cite this

@article{7cf8bcf6f0274e0da80090ebf4518a52,

title = "S627: A review of serious adverse drug reactions (ADRS) from dupilumab (dupixent) reported to the Federal Adverse Event Reporting System (FAERS)",

author = "Yannis Lafazanos and Ehrenpreis, \{Eli D.\}",

year = "2024",

month = oct,

day = "1",

doi = "10.14309/01.ajg.0001031876.62582.d1",

language = "American English",

journal = "American Journal of Gastroenterology",

}

TY - JOUR

T1 - S627: A review of serious adverse drug reactions (ADRS) from dupilumab (dupixent) reported to the Federal Adverse Event Reporting System (FAERS)

AU - Lafazanos, Yannis

AU - Ehrenpreis, Eli D.

PY - 2024/10/1

Y1 - 2024/10/1

U2 - 10.14309/01.ajg.0001031876.62582.d1

DO - 10.14309/01.ajg.0001031876.62582.d1

M3 - Meeting abstract

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

ER -